vr

New technology allows scientists to study the inside of cells using VR

pharmafile | October 20, 2020 | News story | Manufacturing and Production, Research and Development VR, Virtual reality, pharma 

New virtual reality software allows researchers to “walk” inside cells and analyse them up close in order to better understand the development of diseases and how best to treat them.

The software, named vLUME, was created by scientists at the University of Cambridge and Lume VR and allows high resolution microscopy data to be visualised and analysed in virtual reality (VR). In their research published on Nature, the team describe it as “a virtual reality software package designed to render large three-dimensional single-molecule localisation microscopy datasets”.

“vLUME features include visualisation, segmentation, bespoke analysis of complex local geometries and exporting features,” the team explained. “It can perform complex analysis on real three-dimensional biological samples that would otherwise be impossible by using regular flat-screen visualisation programs.”

The software allows data sets with millions of different data points to be loaded into the program and finds patterns in the data through its in-built algorithms. These can then be shared with other researchers worldwide using the imaging and video software.

Advertisement

Lume CEO Alexandre Kitching commented on the project: “Data generated from super-resolution microscopy is extremely complex. For scientists, running analysis on this data can be very time-consuming. With vLUME, we have managed to vastly reduce that wait time allowing for more rapid testing and analysis.”

Conor Kavanagh

Related Content

drug-trials

LGC Group opens $100M Organic Chemistry Synthesis Centre of Excellence

LGC Group, a life sciences company, has opened its new Organic Chemistry Synthesis Centre of …

blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed …

Bend Bioscience adds commercial spray drying facility to Georgia site

Bend Bioscience has announced the addition of a commercial-scale spray dryer and a Gerteis dry …

The Gateway to Local Adoption Series

Latest content